The diagnosis and management of monogenic diabetes in children and adolescents
暂无分享,去创建一个
A. Hattersley | S. Ellard | P. Njølstad | N. White | W. Młynarski | M. Craig | Ó. Rubio-Cabezas | D. Chí | Sian Ellard | D. V. Chí | Andrew Hattersley | Pål R. Njølstad | Wojciech Młynarski | Neil White | Maria E. Craig
[1] C. Acerini,et al. Management of cystic fibrosis‐related diabetes in children and adolescents , 2014, Pediatric diabetes.
[2] T. Hansen,et al. Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3 , 2014, Diabetes.
[3] M. Borowiec,et al. Population‐based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK‐MODY , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[4] T. Hansen,et al. Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial , 2014, Diabetes Care.
[5] K. Raile,et al. Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3) , 2014, Pediatrics.
[6] M. Skopkova,et al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed , 2014, Diabetologia.
[7] S. Bens,et al. Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related , 2014, European Journal of Human Genetics.
[8] R. Steeds,et al. Modification of severe insulin resistant diabetes in response to lifestyle changes in Alström syndrome. , 2014, European journal of medical genetics.
[9] T. Hansen,et al. Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model , 2014, BMC Genetics.
[10] B. Shields,et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. , 2014, JAMA.
[11] P. Froguel,et al. Highly Sensitive Diagnosis of 43 Monogenic Forms of Diabetes or Obesity Through One-Step PCR-Based Enrichment in Combination With Next-Generation Sequencing , 2014, Diabetes Care.
[12] A. Hattersley,et al. Analysis of Transcription Factors Key for Mouse Pancreatic Development Establishes NKX2-2 and MNX1 Mutations as Causes of Neonatal Diabetes in Man , 2014, Cell metabolism.
[13] M. Borowiec,et al. Delayed Recognition of Wolfram Syndrome Frequently Misdiagnosed as Type 1 Diabetes with Early Chronic Complications , 2014, Experimental and Clinical Endocrinology & Diabetes (Barth).
[14] S. Gygi,et al. Carboxyl-Ester Lipase Maturity-Onset Diabetes of the Young Is Associated With Development of Pancreatic Cysts and Upregulated MAPK Signaling in Secretin-Stimulated Duodenal Fluid , 2013, Diabetes.
[15] Aaron N. Winn,et al. Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications , 2013, Diabetes Care.
[16] T. Chatila,et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. , 2013, Current opinion in pediatrics.
[17] B. Shields,et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype , 2013, Journal of Medical Genetics.
[18] Anna Murray,et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis , 2013, Nature Genetics.
[19] R. Scharfmann,et al. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. , 2013, The lancet. Diabetes & endocrinology.
[20] B. Shields,et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia , 2013, Diabetologia.
[21] V. Parker,et al. Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know. , 2013, European journal of endocrinology.
[22] S. Ellard,et al. Diabetes Mellitus in Neonates and Infants: Genetic Heterogeneity, Clinical Approach to Diagnosis, and Therapeutic Options , 2013, Hormone Research in Paediatrics.
[23] Olivier Poch,et al. Exome sequencing of Bardet–Biedl syndrome patient identifies a null mutation in the BBSome subunit BBIP1 (BBS18) , 2013, Journal of Medical Genetics.
[24] Richard Sinnott,et al. EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome , 2013, BMC Pediatrics.
[25] A. Molven,et al. Exocrine pancreatic function in hepatocyte nuclear factor 1β‐maturity‐onset diabetes of the young (HNF1B‐MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[26] Stefan Johansson,et al. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. , 2013, American journal of human genetics.
[27] M. Weedon,et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing , 2013, Diabetologia.
[28] B. Shields,et al. Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies , 2013, PloS one.
[29] A. Hattersley,et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. , 2013, The Journal of clinical endocrinology and metabolism.
[30] M. Weedon,et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy , 2013, Nature Genetics.
[31] T. Orchard,et al. Current clinical status, glucose control, and complication rates of children and youth with type 1 diabetes in Rwanda , 2013, Pediatric diabetes.
[32] R. Scharfmann,et al. Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family. , 2013, Diabetes & metabolism.
[33] A. Molven,et al. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry , 2013, Diabetologia.
[34] F. Ashcroft,et al. Switching to Sulphonylureas in Children With iDEND Syndrome Caused by KCNJ11 Mutations Results in Improved Cerebellar Perfusion , 2013, Diabetes Care.
[35] V. Nunes,et al. Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype , 2013, Genetics in Medicine.
[36] A. Hattersley,et al. Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype–phenotype correlation in an international cohort of patients , 2013, Diabetologia.
[37] E. Mercuri,et al. Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226‐232 mutation , 2012, Pediatric diabetes.
[38] J. Gleeson,et al. A Homozygous IER3IP1 Mutation Causes Microcephaly With Simplified Gyral Pattern, Epilepsy, and Permanent Neonatal Diabetes Syndrome (MEDS) , 2012, American journal of medical genetics. Part A.
[39] A. Hattersley,et al. Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans , 2012, Archives of Disease in Childhood.
[40] C. Stanley,et al. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. , 2012, The Journal of clinical endocrinology and metabolism.
[41] M. Borowiec,et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign , 2012, Diabetologia.
[42] A. Hattersley,et al. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life , 2012, Pediatric diabetes.
[43] J. Aerts,et al. Exome Sequencing and Genetic Testing for MODY , 2012, PloS one.
[44] S. Wiegand,et al. Diabetes mellitus in children and adolescents with genetic syndromes. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[45] C. Quittner,et al. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety. , 2012, The Journal of clinical endocrinology and metabolism.
[46] P. Taschner,et al. In search of triallelism in Bardet–Biedl syndrome , 2012, European Journal of Human Genetics.
[47] A. Hattersley,et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans , 2011, Nature Genetics.
[48] S. Wiegand,et al. Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. , 2011, Diabetes research and clinical practice.
[49] G. Bell,et al. MODY: history, genetics, pathophysiology, and clinical decision making. , 2011, Diabetes care.
[50] K. Rahmouni,et al. Molecular basis of the obesity associated with Bardet–Biedl syndrome , 2011, Trends in Endocrinology & Metabolism.
[51] E. Cummings,et al. Presentation and course of diabetes in children and adolescents with Alstrom syndrome , 2011, Pediatric diabetes.
[52] A. Hattersley,et al. Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3 , 2011, Diabetes.
[53] F. Cerutti,et al. Permanent diabetes during the first year of life: multiple gene screening in 54 patients , 2011, Diabetologia.
[54] Aaron N. Winn,et al. The Cost-Effectiveness of Personalized Genetic Medicine , 2011, Diabetes Care.
[55] R. Ravazzolo,et al. Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a new familial GATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[56] F. Ashcroft,et al. SYMPOSIUM REVIEW: The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet , 2010, The Journal of physiology.
[57] J. Lalau. Lactic Acidosis Induced by Metformin , 2010, Drug safety.
[58] L. Philipson,et al. Neonatal diabetes mellitus: A model for personalized medicine , 2010, Trends in Endocrinology & Metabolism.
[59] F. Ashcroft,et al. Muscle Dysfunction Caused by a KATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin , 2010, Science.
[60] Sian Ellard,et al. Homozygous Mutations in NEUROD1 Are Responsible for a Novel Syndrome of Permanent Neonatal Diabetes and Neurological Abnormalities , 2010, Diabetes.
[61] B. Shields,et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.
[62] S. Ellard,et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations , 2010, European journal of endocrinology.
[63] J. Skupień,et al. Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up. , 2010, Diabetes technology & therapeutics.
[64] D. Dunger,et al. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. , 2010, The Journal of clinical endocrinology and metabolism.
[65] B. Shields,et al. Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[66] A. Hattersley,et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis , 2010, Proceedings of the National Academy of Sciences.
[67] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[68] K. Dewar,et al. Rfx6 Directs Islet Formation and Insulin Production in Mice and Humans , 2009, Nature.
[69] Ó. Rubio-Cabezas. Diagnosing monogenic diabetes: common misinterpretations of genetic findings , 2009, Pediatric diabetes.
[70] J. Hahn,et al. Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia , 2009, American journal of medical genetics. Part A.
[71] A. Hattersley,et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. , 2009, The Journal of clinical endocrinology and metabolism.
[72] J. Argente,et al. Testing for monogenic diabetes among children and adolescents with antibody‐negative clinically defined Type 1 diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[73] A. Moran,et al. Management of cystic fibrosis‐related diabetes in children and adolescents , 2009, Pediatric diabetes.
[74] H. Gin,et al. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. , 2009, The Journal of clinical endocrinology and metabolism.
[75] E. Mahone,et al. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15‐yr‐old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM , 2009, Pediatric diabetes.
[76] D. Horn,et al. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. , 2009, The Journal of clinical endocrinology and metabolism.
[77] G. d’Annunzio,et al. Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia: , 2009, Diabetes Care.
[78] A. Hattersley,et al. Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide , 2009, Diabetes Care.
[79] B. Shields,et al. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[80] F. Meschi,et al. Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies , 2009, Diabetes Care.
[81] A. Hattersley,et al. Clinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes , 2009, Diabetes Care.
[82] P. Ruszniewski,et al. The natural history of hereditary pancreatitis: a national series , 2008, Gut.
[83] A. Hattersley,et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 , 2008, Nature Genetics.
[84] A. Molven,et al. Lack of pancreatic body and tail in HNF1B mutation carriers , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[85] T. Hansen,et al. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. , 2008, The Journal of clinical investigation.
[86] A. Hattersley,et al. Persistent Hyperinsulinemic Hypoglycemia and Maturity-onset Diabetes of the Young Due to Heterozygous Hnf4a Mutations , 2022 .
[87] P. Yong,et al. Use of Sirolimus in IPEX and IPEX-Like Children , 2008, Journal of Clinical Immunology.
[88] Geir Joner,et al. Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes , 2008, Diabetes.
[89] R. Scharfmann,et al. Heterozygous Missense Mutations in the Insulin Gene Are Linked to Permanent Diabetes Appearing in the Neonatal Period or in Early Infancy , 2008, Diabetes.
[90] F. Cadario,et al. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. , 2008, The Journal of clinical endocrinology and metabolism.
[91] A. Hattersley,et al. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[92] S. Ellard,et al. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young , 2008, Diabetologia.
[93] C. Bellanné-Chantelot,et al. The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 , 2008, Diabetes.
[94] A. Hattersley,et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. , 2008, Diabetes.
[95] D. Eizirik,et al. The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.
[96] F. Crispim,et al. Sulfonylrea Treatment in Permanent Neonatal Diabetes Due to G53D Mutation in the KCNJ11 Gene , 2007, Diabetes Care.
[97] F. Ashcroft,et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11 , 2007, Nature Clinical Practice Neurology.
[98] M. Zhang,et al. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. , 2007, American journal of human genetics.
[99] A. Hattersley,et al. Insulin gene mutations as a cause of permanent neonatal diabetes , 2007, Proceedings of the National Academy of Sciences.
[100] F. Ashcroft,et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. , 2007, American journal of human genetics.
[101] G. Sebag,et al. Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy , 2007, Pediatrics.
[102] A. Hattersley,et al. Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings. , 2007, The Journal of clinical endocrinology and metabolism.
[103] A. Hattersley,et al. Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene , 2007, PLoS medicine.
[104] P. Beales,et al. Bardet–Biedl syndrome: beyond the cilium , 2007, Pediatric Nephrology.
[105] A. Molven,et al. Pancreatic Lipomatosis Is a Structural Marker in Nondiabetic Children With Mutations in Carboxyl-Ester Lipase , 2007, Diabetes.
[106] S. Ellard,et al. Hepatocyte nuclear factor‐1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF‐1β in human pancreatic development , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[107] A. Hattersley,et al. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene , 2006, Diabetologia.
[108] R. Scharfmann,et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.
[109] F. Ashcroft,et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.
[110] A. Hattersley,et al. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. , 2006, Human molecular genetics.
[111] R. Siebert,et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus , 2006, Human Genetics.
[112] P. Bingley,et al. HLA Genotyping Supports a Nonautoimmune Etiology in Patients Diagnosed With Diabetes Under the Age of 6 Months , 2006, Diabetes.
[113] F. Ashcroft,et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. , 2006, Human molecular genetics.
[114] C. Julier,et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism , 2006, Nature Genetics.
[115] A. Hattersley,et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features , 2006, European Journal of Human Genetics.
[116] A. Hattersley,et al. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype , 2006, Diabetologia.
[117] T. Hansen,et al. Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents , 2006, European Journal of Pediatrics.
[118] P. Massin,et al. Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. , 2006, Diabetes & metabolism.
[119] V. Nunes,et al. Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. , 2006, Pediatric endocrinology reviews : PER.
[120] L. Groop,et al. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. , 2006, Diabetes care.
[121] M. Jadoul,et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. , 2005, Diabetes.
[122] F. Ashcroft,et al. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. , 2005, Diabetes.
[123] H. Ochs,et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). , 2005, The Journal of pediatrics.
[124] F. Ashcroft. ATP-sensitive potassium channelopathies: focus on insulin secretion. , 2005, The Journal of clinical investigation.
[125] A. Hattersley,et al. β-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1α Mutation Carriers , 2005 .
[126] F. Matschinsky. Glucokinase, glucose homeostasis, and diabetes mellitus , 2005, Current diabetes reports.
[127] A. Hattersley,et al. Mutations in hepatocyte nuclear factor-1β and their related phenotypes , 2005, Journal of Medical Genetics.
[128] T. Hansen,et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection , 2005, Diabetologia.
[129] A. Hattersley,et al. High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. , 2005, Diabetes care.
[130] A. Hattersley,et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis , 2004, Nature Genetics.
[131] A. Hattersley,et al. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[132] A. Hattersley,et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. , 2004, Diabetes.
[133] A. Hattersley,et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. , 2004, Diabetes.
[134] G. Rutter,et al. Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM. , 2004, The Journal of clinical investigation.
[135] G. Lathrop,et al. Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. , 2004, Diabetes.
[136] Simeon I. Taylor,et al. Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes): A 30-Year Prospective , 2004, Medicine.
[137] M. Polak,et al. An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[138] T. Nakahata,et al. Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism. , 2004, The Journal of clinical endocrinology and metabolism.
[139] A. Hattersley,et al. Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations , 2004 .
[140] F. Ashcroft,et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.
[141] Christine Bellann-Chantelot,et al. Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1 Mutations , 2004, Annals of Internal Medicine.
[142] H. Gin,et al. Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). , 2004, Diabetes & metabolism.
[143] A. Garg. Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.
[144] G. Nijpels,et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. , 2004, Diabetes.
[145] A. Molven,et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. , 2003, Diabetes.
[146] A. Hattersley,et al. Genetic cause of hyperglycaemia and response to treatment in diabetes , 2003, The Lancet.
[147] A. Hattersley,et al. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[148] S. O’Rahilly,et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.
[149] P. Bingley,et al. Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. , 2003, Diabetes care.
[150] J. Shield,et al. Transient neonatal diabetes, a disorder of imprinting , 2002, Journal of medical genetics.
[151] M. Martinetti,et al. Permanent diabetes mellitus in the first year of life , 2002, Diabetologia.
[152] H. Yoo,et al. Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosaemia , 2002, European Journal of Pediatrics.
[153] David I. Wilson,et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome , 2002, Nature Genetics.
[154] T. Hansen,et al. The genetic abnormality in the beta cell determines the response to an oral glucose load , 2002, Diabetologia.
[155] G I Bell,et al. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.
[156] Bethan E. Hoskins,et al. Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder , 2001, Science.
[157] E. Bonifacio,et al. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study. , 2001, Diabetes Care.
[158] A. Molven,et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. , 2001, The New England journal of medicine.
[159] F. Khanim,et al. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases , 2001, Human mutation.
[160] A. Franzese,et al. MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”? , 2000, Diabetologia.
[161] G. Lathrop,et al. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome , 2000, Nature Genetics.
[162] J. Barber,et al. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. , 2000, Diabetes.
[163] R. Siebert,et al. An imprinted locus associated with transient neonatal diabetes mellitus. , 2000, Human molecular genetics.
[164] A. M. Møller,et al. Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having Type I diabetes , 1998, Diabetologia.
[165] P. Behn,et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.
[166] R. Tattersall,et al. Maturity‐onset diabetes of the young: a clinical history , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[167] T. Hansen,et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.
[168] A. Hattersley,et al. Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12 , 1996, Diabetes.
[169] T. Barrett,et al. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.
[170] M. B. Brown,et al. Administration of Sulfonylureas Can Increase Glucose-Induced Insulin Secretion for Decades in Patients With Maturity-Onset Diabetes of the Young , 1993, Diabetes Care.
[171] M. Stoffel,et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.
[172] I. Nonaka,et al. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.
[173] H. Mandel,et al. Thiamine-dependent beriberi in the "thiamine-responsive anemia syndrome". , 1984, The New England journal of medicine.
[174] A. Arbor,et al. A Difference Between the Inheritance of Classical Juvenile-onset and Maturity-onset Type Diabetes of Young People , 1975, Diabetes.
[175] R. Tattersall. Mild familial diabetes with dominant inheritance. , 1974, The Quarterly journal of medicine.
[176] Stephen O’Riordana,et al. Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .
[177] S. Davies,et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. , 2007, Blood.
[178] A. Molven,et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction , 2006, Nature Genetics.
[179] C. Bellanné-Chantelot,et al. Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. , 2006, Journal of the American Society of Nephrology : JASN.
[180] J. Girard. Hormonal Regulation of Fetal Growth , 2006 .
[181] R. Gitzelmann,et al. Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA , 2005, European Journal of Pediatrics.
[182] A. Hattersley,et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. , 2005, Diabetes care.
[183] A. Hattersley,et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. , 2004, Diabetes care.
[184] G. Nijpels,et al. Molecular mechanisms and clinical presentation , 2004 .
[185] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[186] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[187] L. Groop,et al. Chronic diabetic complications in patients with MODY3 diabetes , 1998, Diabetologia.
[188] William L. Clarke,et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.
[189] P. Froguel,et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families , 1997, Diabetologia.
[190] G. Bell,et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. , 1997, Nature genetics.
[191] M. Stoffel,et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.
[192] L. Nilsson,et al. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. , 1959, Acta psychiatrica et neurologica Scandinavica. Supplementum.